TECHNOLOGY

Our Solution

SymbiO-2 has developed a photosynthetic scaffold technology (SymbiO-Derm) that provides physicians with next-generation tools for the treatment, unctional restoration, and healing of damaged or diseased tissues

Incorporate a three-dimensional photosynthetic matrix that is designed for application directly over acute and chronic skin wounds

Exposing the matrix dressing to light produces oxygen, which aids in the ingrowth of healthy tissue, with the potential to close the wound (first prototype or “Basic Platform”). Additionally, for our second-generation prototype (Molecular Platform), will have the capability to engineer our photosynthetic scaffold to produce wound-healing factors for each of the four stages of the wound healing process: hemostasis, inflammation, proliferation, and remodeling

Prototype has been tested in preclinical settings:

  • Prototype validated (oxygen production in the presence of light)
  • Our basic platform product decreased wound-healing times and improved wound-healing quality
  • Molecular platform showed ability to deliver pro-healing factors
  • No adverse effects were observed after 21 days of exposure

Ip Granted

EP2550025A1

Use of photosynthetic scaffolds in tissue engineering

Patent Pending

CT/US2015/048435

Photosynthetic Cellular Substances and Methods of

Use Thereof

Competitive Advantage

SymbiO-2’s photosynthetic scaffold technology is the ONLY one that provides oxygen delivery as well as desired pro-regeneration molecules locally to the wound site. With these two novel approaches, oxygen and pro-regeneration molecule delivery at the wound site, our wound healing treatment should accelerate & improve significantly dermal tissue repair, therefore playing an active role in the tissue regeneration process